The regulatory mechanisms of CAA in breast cancer are complex, including inflammatory adipokine secretions such as IL-1β, CCL2, TNFα, CCL5, and leptin, as well as IL-6 metabolic reprogramming by altering the metabolism of macronutrients and remodeling of the extracellular matrix [158,159]. Here, CCL2 is linked to breast cancer.